eFFECTOR Therapeutics, Inc. (EFTR) DCF Valuation

eFFECTOR Therapeutics, Inc. (EFTR) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

eFFECTOR Therapeutics, Inc. (EFTR) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Explore eFFECTOR Therapeutics, Inc. (EFTR) financial outlook with our user-friendly DCF Calculator! Enter your projections for growth, margins, and expenses to determine eFFECTOR Therapeutics, Inc. (EFTR)'s intrinsic value and inform your investment approach.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 42.0 1.4 3.6 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 -96.6 148.46 -100 -24.15 -24.15 -24.15 -24.15 -24.15
EBITDA -28.3 16.1 -31.9 -32.4 -33.7 .0 .0 .0 .0 .0
EBITDA, % 100 38.23 -2230.56 -911.99 100 7.65 7.65 7.65 7.65 7.65
Depreciation .3 .2 .0 .1 .1 .0 .0 .0 .0 .0
Depreciation, % 100 0.38095 1.68 1.49 100 40.71 40.71 40.71 40.71 40.71
EBIT -28.6 15.9 -31.9 -32.5 -33.8 .0 .0 .0 .0 .0
EBIT, % 100 37.85 -2232.24 -913.48 100 7.57 7.57 7.57 7.57 7.57
Total Cash 3.4 15.2 49.7 26.3 18.4 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 0 0 0 100
Inventories .0 .0 -.1 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 0 -6.99 -0.75992 100 38.45 38.45 38.45 38.45 38.45
Accounts Payable .6 .3 .5 1.5 2.3 .0 .0 .0 .0 .0
Accounts Payable, % 100 0.82619 36.08 41.82 100 55.75 55.75 55.75 55.75 55.75
Capital Expenditure .0 -.2 .0 -.2 -.1 .0 .0 .0 .0 .0
Capital Expenditure, % 100 -0.36667 -2.94 -5.4 100 -1.74 -1.74 -1.74 -1.74 -1.74
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -28.6 15.5 -31.9 -18.5 -33.8 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -27.7 15.3 -31.7 -17.8 -33.0 -2.3 .0 .0 .0 .0
WACC, % 4.45 4.34 4.45 2.54 4.45 4.05 4.05 4.05 4.05 4.05
PV UFCF
SUM PV UFCF -2.2
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -2
Net Debt 6
Equity Value -8
Diluted Shares Outstanding, MM 2
Equity Value Per Share -3.62

What You Will Get

  • Pre-Filled Financial Model: eFFECTOR Therapeutics’ actual data enables precise DCF valuation.
  • Full Forecast Control: Adjust revenue growth, margins, WACC, and other key drivers for [EFTR].
  • Instant Calculations: Automatic updates ensure you see results as you make changes to the [EFTR] model.
  • Investor-Ready Template: A refined Excel file designed for professional-grade valuation of [EFTR].
  • Customizable and Reusable: Tailored for flexibility, allowing repeated use for detailed forecasts on [EFTR].

Key Features

  • Customizable Clinical Parameters: Adjust essential inputs such as treatment efficacy, patient demographics, and market penetration.
  • Instant DCF Valuation: Quickly computes intrinsic value, NPV, and other financial metrics.
  • Industry-Leading Precision: Incorporates eFFECTOR Therapeutics’ real-world data for accurate valuation results.
  • Effortless Scenario Analysis: Evaluate various hypotheses and analyze results with ease.
  • Efficiency Booster: Remove the hassle of constructing intricate valuation models from the ground up.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based eFFECTOR Therapeutics DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other key inputs.
  3. Instant Calculations: The model automatically recalculates the intrinsic value of eFFECTOR Therapeutics (EFTR).
  4. Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
  5. Analyze and Decide: Leverage the results to inform your investment or financial analysis decisions.

Why Choose eFFECTOR Therapeutics, Inc. (EFTR) Calculator?

  • Designed for Experts: A sophisticated tool tailored for researchers, investors, and healthcare analysts.
  • Comprehensive Data: eFFECTOR’s historical and projected financials integrated for precise analysis.
  • Flexible Scenario Analysis: Effortlessly test various outcomes and assumptions.
  • Insightful Outputs: Automatically computes intrinsic value, NPV, and essential financial metrics.
  • User-Friendly: Step-by-step guidance ensures a smooth user experience.

Who Should Use This Product?

  • Pharmaceutical Researchers: Explore innovative therapeutic approaches and evaluate their potential using real-world data.
  • Healthcare Academics: Integrate advanced models into educational programs or scholarly research.
  • Investors: Analyze your investment strategies and assess the valuation metrics for eFFECTOR Therapeutics, Inc. (EFTR).
  • Market Analysts: Enhance your analysis with a customizable financial model tailored to biotech firms.
  • Entrepreneurs in Biotech: Understand how established companies like eFFECTOR Therapeutics, Inc. (EFTR) are valued in the market.

What the Template Contains

  • Preloaded EFTR Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.